FIELD: medicine. SUBSTANCE: composition contains, mg: cation-exchange resin containing bivalent iron 20-60, cation-exchange resin in cobalt form having cobalt content 2-6, ascorbic acid 25-75. Above mentioned cation-exchange resin in iron and cobalt form is used as source of iron and cobalt ions. Thus absorption and assimilation of iron ions in the presence of ascorbic acid is improved; due to prolonged simultaneously adding iron and cobalt ions hemopoiesis is increased. EFFECT: increases antianemia effect, decreases by-effects. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIANEMIC AGENT | 1996 |
|
RU2079307C1 |
METHOD FOR COMPLEX PROCESSING AGRICULTURAL ANIMALS BLOOD FOR PREPARING HEMOGLOBIN-BASE BIOLOGICALLY ACTIVE SUBSTANCE WITH ANTI-ANEMIC PROPERTIES, BIOLOGICALLY ACTIVE SUBSTANCE WITH ANTI-ANEMIC PROPERTIES (VARIANTS) AND PRODUCT COMPRISING THEREOF (VARIANTS) | 2004 |
|
RU2274003C2 |
METHOD FOR PRODUCING A BIOLOGICALLY ACTIVE COMPLEX IODINE-METABOLIC PREPARATION FOR STIMULATING ERYTHROPOIESIS, ENERGY METABOLISM, PREVENTING AN ANEMIC SYNDROME, HYPOXIA, HYPOMICROELEMENTOSES | 2020 |
|
RU2757367C1 |
COMPOSITION FOR PREVENTION OF IRON DEFICIENCY ANEMIA | 2012 |
|
RU2491948C1 |
PHARMACOLOGICAL COMPOSITION FOR IRON DEFICIENCY ANEMIA TREATMENT | 2021 |
|
RU2763135C1 |
PREPARATION FOR TREATING AND PREVENTING IRON-DEFICIENT CONDITIONS IN ANIMALS | 2010 |
|
RU2455999C2 |
BIOLOGICALLY ACTIVE FOOD ADDITIVE | 2024 |
|
RU2838872C1 |
PHARMACOLOGICAL COMPOSITION ON BASIS OF IRON COMPOUNDS | 2016 |
|
RU2625739C1 |
AGENT ELICITING ANTIANEMIC AND IMMUNOMODULATING ACTIVITY | 2001 |
|
RU2208440C2 |
CURATIVE-NUTRIENT AGENT | 1998 |
|
RU2132686C1 |
Authors
Dates
1994-05-15—Published
1988-03-04—Filed